References
- Biaik J., Coghlan D., Langer E., Jansen M., Askey-Sarvar A. Sustained delivery of insulin via the lung using SoliDoser` technology. Proceedings of Respiratory Drug Delivery VIII, R. Dalby, P. R. Byron, J. Peart, S. Farr. RDD Online, Richmond 2002; Vol. 2: 411–414
- Diminsky D., Moav N., Gorrecki M., Barenholz Y. Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles. Vaccine 1999; 18: 3–17
- Gav F. Ilanes, Gomez-Gutlerrez J., Aracil M., Gonzalezros J. M., Ferragut J. A., Guerrero E., Peterson D. L. Hepatitis B surface antigen: role of lipids in maintaining the structural and antigenic properties of protein components. Biochemical Journal 1990; 265: 857–864
- Gribbon E. M., Hatley R. H. M., Gard T., Blair J. A., Kampinga J., Roser B. Trehalose and novel hydrophobic sugar glasses in drug stabilisation and delivery. Chemical Aspects of Drug Delivery Systems, D. R. Karsa, R. A. Stephenson. Royal Society of Chemistry, London 1996; 138–145
- Hillery A. Microparticulate carriers: potential mucosal delivery systems for drugs and vaccines. 1997–98; 65–69, Drug Delivery Companies Report
- Johansen P., Men Y., Merkle H. P., Gander B. Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination. European Journal of Pharmaceutics and Biopharmaceutics 2000; 50: 129–146
- Mestecky J., Moldoveanu Z., Novak M., Huang W. Q., Gilley R. M., Staas J. K., Schafer D., Compans R. W. Biodegradable microspheres for the delivery of oral vaccines. Journal of Controlled Release 1994; 28: 131–141
- Morris W., Steinhoff M. C., Russell P. K. Potential of polymer microencapsulation technology for vaccine innovation. Vaccine 1994; 12: 5–11
- Nellore R. V., Pande P. G., Young D., Bhagat H. R. Evaluation of biodegradable microspheres as vaccine adjuvant for hepatitis B surface antigen. Journal of Parenteral Science and Technology 1992; 46: 176–180
- Sabbaj S., Kiyono H., McGnee J. R. Mucosal immunisation for enteric diseases. Current Practice and Future Prospects. BioDrugs 1997; 7: 134–157
- Singh M., Li X.-M., McGee J. P., Zamb T., Koff W., Wang C. Y., O'Hagan D. T. Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice. Vaccine 1997; 15: 475–481
- Van De Weert M., Hennink W. E., Jisjoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharmaceutical Research 2000; 17: 1159–1167